Allscripts (MDRX) Tops Q3 EPS by 5c; Withdrawing Guidance; to Evaluate Alternatives
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/26/2026
- Wall St muted ahead of Nvidia results, hot inflation fuels rate-hike bets
- Oil slips as investors focus on Hormuz talks
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Boston Scientific discloses cybersecurity incident causing global disruption
- Wall Street ends higher as tech rebounds before Nvidia results
- Six Flags to move headquarters from Charlotte to Arlington, Texas
- Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
Piper Jaffray Downgrades Allscripts (MDRX) to Underweight
November 9, 2012 6:54 AM ESTPiper Jaffray downgraded Allscripts (NASDAQ: MDRX) from Neutral to Underweight with a price target of $7.00 (from $12.00) following Q3 results and announcement that it will explore alternatives.
For an analyst ratings summary and ratings history on Allscripts... More
Allscripts-Misys (MDRX) Resumes, Shares Higher in Late Trading
November 8, 2012 4:40 PM ESTAllscripts-Misys Healthcare Solution (NASDAQ: MDRX) resumes trading with the stock up over 7 percent in the late session Thursday.... More
Allscripts-Misys Healthcare Solution (MDRX) halted, news pending
November 8, 2012 4:02 PM ESTAllscripts-Misys Healthcare Solution (NASDAQ: MDRX) halted, news pending... More
